These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24213602)

  • 21. Systemic Levels of Estrogens and PGE
    Kim S; Campbell J; Yoo W; Taylor JA; Sandler DP
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):383-388. PubMed ID: 27864342
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen metabolism and mammographic density in postmenopausal women: a cross-sectional study.
    Fuhrman BJ; Brinton LA; Pfeiffer RM; Xu X; Veenstra TD; Teter BE; Byrne C; Dallal CM; Barba M; Muti PC; Gierach GL
    Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1582-91. PubMed ID: 22736791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen metabolism and excretion in Oriental and Caucasian women.
    Adlercreutz H; Gorbach SL; Goldin BR; Woods MN; Dwyer JT; Hämäläinen E
    J Natl Cancer Inst; 1994 Jul; 86(14):1076-82. PubMed ID: 8021957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of multiplex endogenous estrogen metabolites in human urine using ultra-fast liquid chromatography-tandem mass spectrometry: a case study for breast cancer.
    Huang J; Sun J; Chen Y; Song Y; Dong L; Zhan Q; Zhang R; Abliz Z
    Anal Chim Acta; 2012 Jan; 711():60-8. PubMed ID: 22152797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses' Health Study.
    Brantley KD; Ziegler RG; Craft NE; Hankinson SE; Eliassen AH
    Cancer Epidemiol Biomarkers Prev; 2024 Aug; ():. PubMed ID: 39190182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary concentrations of estrogens and estrogen metabolites and smoking in caucasian women.
    Gu F; Caporaso NE; Schairer C; Fortner RT; Xu X; Hankinson SE; Eliassen AH; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):58-68. PubMed ID: 23104668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
    Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
    Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of established breast cancer risk factors with urinary estrogens in postmenopausal women.
    Yaghjyan L; Darville LNF; Cline J; Martinez YC; Rich S; Austin-Datta RJ; Koomen JM; Tworoger SS; Egan KM
    Cancer Causes Control; 2022 Feb; 33(2):279-291. PubMed ID: 34988766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2029-35. PubMed ID: 18708395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status.
    Coburn SB; Stanczyk FZ; Falk RT; McGlynn KA; Brinton LA; Sampson J; Bradwin G; Xu X; Trabert B
    Cancer Causes Control; 2019 Jan; 30(1):75-86. PubMed ID: 30506492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
    Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
    Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
    Adly L; Hill D; Sherman ME; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Schairer C
    Int J Cancer; 2006 Nov; 119(10):2402-7. PubMed ID: 16894564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers.
    Loud JT; Gierach GL; Veenstra TD; Falk RT; Nichols K; Guttmann A; Xu X; Greene MH; Gail MH
    Breast Cancer Res Treat; 2014 Feb; 143(3):517-29. PubMed ID: 24442642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dietary pattern derived to correlate with estrogens and risk of postmenopausal breast cancer.
    Fung TT; Schulze MB; Hu FB; Hankinson SE; Holmes MD
    Breast Cancer Res Treat; 2012 Apr; 132(3):1157-62. PubMed ID: 22218885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women.
    Key TJ; Appleby PN; Reeves GK; Roddam A; Dorgan JF; Longcope C; Stanczyk FZ; Stephenson HE; Falk RT; Miller R; Schatzkin A; Allen DS; Fentiman IS; Key TJ; Wang DY; Dowsett M; Thomas HV; Hankinson SE; Toniolo P; Akhmedkhanov A; Koenig K; Shore RE; Zeleniuch-Jacquotte A; Berrino F; Muti P; Micheli A; Krogh V; Sieri S; Pala V; Venturelli E; Secreto G; Barrett-Connor E; Laughlin GA; Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE; Cauley JA; Kuller LH; Cummings SR; Helzlsouer KJ; Alberg AJ; Bush TL; Comstock GW; Gordon GB; Miller SR; Longcope C;
    J Natl Cancer Inst; 2003 Aug; 95(16):1218-26. PubMed ID: 12928347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
    Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of serum estrogens and metabolites with area and volume mammographic densities.
    Gierach GL; Patel DA; Falk RT; Pfeiffer RM; Geller BM; Vacek PM; Weaver DL; Chicoine RE; Shepherd JA; Mahmoudzadeh AP; Wang J; Fan B; Herschorn SD; Xu X; Veenstra T; Fuhrman B; Sherman ME; Brinton LA
    Horm Cancer; 2015 Jun; 6(2-3):107-19. PubMed ID: 25757805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
    Wang SM; Pfeiffer RM; Gierach GL; Falk RT
    Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.